文献速递肿瘤 PET/CT

68Ga-PSMA-11 PET/CT与mpMRI在前列腺癌检测、定位及局部扩展评估中的头对头比较:前瞻性单中心影像试验

Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial.
PubMed 文献 · J Nucl Med · 2021-10-14

该前瞻性单中心影像试验纳入74例中高危前列腺癌患者,以全mount病理为金标准,比较68Ga-PSMA-11 PET/CT、mpMRI及两者联合在肿瘤检测、前列腺内定位及局部扩展判定中的诊断性能。结果显示PSMA PET/CT与mpMRI在检测和定位上准确性相似,但mpMRI在识别包膜外侵犯和精囊侵犯方面更优;联合影像可改善肿瘤范围勾画。

要点

  • PSMA PET/CT与mpMRI对前列腺癌灶的检测和前列腺内定位准确性相似。
  • mpMRI在识别包膜外侵犯(EPE)和精囊侵犯(SVI)方面优于PSMA PET/CT。
  • 中高危前列腺癌T分期评估仍应以mpMRI为参考影像,联合PET/CT+mpMRI可改善肿瘤范围勾画。

核心结论

  • PSMA PET/CT与mpMRI对前列腺癌灶检测和前列腺内定位准确性相似,但mpMRI在识别EPE和SVI方面表现更优。
  • 中高危前列腺癌T分期评估中,mpMRI仍应被视为参考影像模态。
  • 若条件允许,应使用PSMA PET/MRI或PSMA PET/CT与mpMRI的配准/融合以改善肿瘤范围勾画。

研究设计与样本

  • 前瞻性单中心影像试验(NCT03368547),纳入74例中高危前列腺癌患者(14例[19%]中危,60例[81%]高危)。
  • 患者根治性前列腺切除术前接受PSMA PET/CT和mpMRI,每种模态由3名独立盲法阅片者解读,采用中心多数规则(2:1)。
  • 以全mount病理切片为金标准,采用标准化方法在段水平和病灶水平解读,病灶检测采用「邻近」方法定义影像-病理相关性。
  • 采用ROC曲线分析评估定位、EPE和SVI判定的准确性,采用组内相关系数分析评估阅片者间一致性。

主要发现

  • 病灶水平分析中,PSMA PET/CT、mpMRI及PSMA PET/CT+mpMRI的癌症检出率分别为85%、83%和87%。
  • 段水平分析中,PSMA PET/CT+mpMRI与单独两种模态相比,肿瘤定位勾画的AUC变化有统计学意义(P < 0.001),而PSMA PET/CT与mpMRI之间无统计学差异(P = 0.093)。
  • mpMRI在检测EPE(P = 0.002)和SVI(P = 0.001)方面优于PSMA PET/CT。
  • 段水平分析中,采用5点Likert量表时PSMA PET/CT与mpMRI阅片者间ICC显示中等信度(范围0.53-0.64)。
  • T分期评估中,PSMA PET/CT阅片者间信度差,mpMRI阅片者间信度为差至中等。

关键数值与推荐

  • 癌症检出率(病灶水平):PSMA PET/CT 85%、mpMRI 83%、PSMA PET/CT+mpMRI 87%。
  • 肿瘤定位勾画AUC变化:PSMA PET/CT+mpMRI vs 单独模态 P < 0.001;PSMA PET/CT vs mpMRI P = 0.093。
  • EPE检测:mpMRI优于PSMA PET/CT,P = 0.002。
  • SVI检测:mpMRI优于PSMA PET/CT,P = 0.001。
  • 阅片者间ICC(5点Likert量表,段水平):PSMA PET/CT与mpMRI范围0.53-0.64。

临床怎么用

  • 在中高危前列腺癌的术前评估中,mpMRI仍应作为T分期的参考影像模态。
  • 若条件允许,应采用PSMA PET/MRI或PSMA PET/CT与mpMRI的配准/融合以改善肿瘤范围勾画。
  • PSMA PET/CT与mpMRI在肿瘤检测和前列腺内定位方面准确性相似,可互为补充。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The role of prostate-specific membrane antigen (PSMA)-targeted PET in comparison to multiparametric MRI (mpMRI) in the evaluation of intraprostatic cancer foci is not well defined. The aim of our study was to compare the diagnostic performance of 68Ga-PSMA-11 PET/CT (PSMA PET/CT), mpMRI, and PSMA PET/CT + mpMRI using 3 independent masked readers for each modality and with histopathology as the gold standard in the detection, intraprostatic localization, and determination of local extension of primary prostate cancer. Methods: Patients with intermediate- or high-risk prostate cancer who underwent PSMA PET/CT as part of a prospective trial (NCT03368547) and mpMRI before radical prostatectomy were included. Each imaging modality was interpreted by 3 independent readers who were unaware of the other modality result. A central majority rule was applied (2:1). Pathologic examination of whole-mount slices was used as the gold standard. Imaging scans and whole-mount slices were interpreted using the same standardized approach on a segment level and a lesion level. A "neighboring" approach was used to define imaging-pathology correlation for the detection of individual prostate cancer foci. Accuracy in determining the location, extraprostatic extension (EPE), and seminal vesicle invasion (SVI) of prostate cancer foci was assessed using receiver-operating-characteristic curve analysis. Interreader agreement was calculated using intraclass correlation coefficient analysis. Results: The final analysis included 74 patients (14 [19%] with intermediate risk and 60 [81%] with high risk). The cancer detection rate (lesion-based analysis) was 85%, 83%, and 87% for PSMA PET/CT, mpMRI, and PSMA PET/CT + mpMRI, respectively. The change in AUC was statistically significant between PSMA PET/CT + mpMRI and the 2 imaging modalities alone for delineation of tumor localization (segment-based analysis) (P < 0.001) but not between PSMA PET/CT and mpMRI (P = 0.093). mpMRI outperformed PSMA PET/CT in detecting EPE (P = 0.002) and SVI (P = 0.001). In the segment-level analysis, intraclass correlation coefficient analysis showed moderate reliability among PSMA PET/CT and mpMRI readers using a 5-point Likert scale (range, 0.53-0.64). In the evaluation of T staging, poor reliability was found among PSMA PET/CT readers and poor to moderate reliability was found for mpMRI readers. Conclusion: PSMA PET/CT and mpMRI have similar accuracy in the detection and intraprostatic localization of prostate cancer foci. mpMRI performs better in identifying EPE and SVI. For the T-staging evaluation of intermediate to high-risk prostate cancer, mpMRI should still be considered the imaging modality of reference. Whenever available, PSMA PET/MRI or the coregistration or fusion of PSMA PET/CT and mpMRI (PSMA PET/CT + mpMRI) should be used as it improves tumor extent delineation.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sonni I, Felker ER, Lenis AT, et al. Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial. J Nucl Med. 2021. PMID: 34649942. doi:10.2967/jnumed.121.262398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。